SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-22-040273
Filing Date
2022-07-01
Accepted
2022-07-01 16:43:43
Documents
2
Period of Report
2022-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4544
2 EX-24 DOCUMENT attachment1.htm EX-24 4334
  Complete submission text file 0001209191-22-040273.txt   10288
Mailing Address C/O SALIX PHARMACEUTICALS, LTD. 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address
Forbes William P (Reporting) CIK: 0001314760 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38886 | Film No.: 221062041

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations